0001209191-22-005923.txt : 20220201 0001209191-22-005923.hdr.sgml : 20220201 20220201163641 ACCESSION NUMBER: 0001209191-22-005923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220128 FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pinto Shelly CENTRAL INDEX KEY: 0001857740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 22579412 MAIL ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-28 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001857740 Pinto Shelly C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 VP, Finance and CAO Common Stock 2022-01-28 4 A 0 50000 0.00 A 50446 D The reported shares are represented by restricted stock units, or RSUs, which vest as follows: three-eighths of the RSUs vest on July 3, 2023 and the remaining RSUs vest thereafter in five equal semiannual installments. Includes 446 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. /s/ Peter Garcia, by power of attorney 2022-02-01